What You Should Know:
– OM1, a real-world data, AI, and technology company with a focus on chronic diseases launches two new clinical datasets, Chronic Rhinosinusitis (CRS) and Asthma.
– Both datasets are derived from longitudinal follow-ups of patients seen by specialists and focus on patient characteristics, symptoms, treatments, clinical outcomes and healthcare resource utilization. Rapidly growing, the CRS and Asthma datasets each follow approximately 500,000 patients in the U.S.
– The research-grade, real-world data available in the OM1 Respiratory & ENT Network is built with an exclusive partnership between OM1 and the American Academy of Otolaryngology and Head and Neck Surgery Foundation (AAO-HNSF). With access to thousands of clinicians and more than 25 million patient visits across all 50 states, the data is rich with the most representative network available, including patient-reported outcomes, social determinants of health, and patient subtypes and classification data.
